enGene Therapeutics, Inc. (ENGN)
1.81
+0.03
(+1.69%)
USD |
NASDAQ |
Aug 24, 16:00
1.82
+0.01
(+0.55%)
After-Hours: 20:00
enGene Therapeutics Shareholders Equity (Quarterly) : 255.17M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 255.17M |
| January 31, 2026 | 281.55M |
| October 31, 2025 | 167.71M |
| July 31, 2025 | 200.67M |
| April 30, 2025 | 227.29M |
| January 31, 2025 | 249.95M |
| October 31, 2024 | 272.61M |
| July 31, 2024 | 230.33M |
| April 30, 2024 | 242.97M |
| January 31, 2024 | 62.38M |
| October 31, 2023 |
| Date | Value |
|---|---|
| September 30, 2023 | 123.58M |
| July 31, 2023 | -0.0725M |
| June 30, 2023 | 124.36M |
| March 31, 2023 | 127.07M |
| December 31, 2022 | 127.42M |
| September 30, 2022 | 126.80M |
| June 30, 2022 | 126.73M |
| March 31, 2022 | 126.99M |
| December 31, 2021 | 127.39M |
| September 30, 2021 | 0.0143M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 614.86M |
| Medicus Pharma Ltd. | -1.243M |
| Sirona Biochem Corp. | -- |
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Psyence Biomedical Ltd. | 11.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 307.52M |
| Total Liabilities (Quarterly) | 52.36M |
| Debt to Equity Ratio | 0.1307 |
| Current Ratio | 12.57 |
| Net Debt Paydown Yield | -0.34% |